Patients carrying PNPLA2 mutations that resulted in the loss or decreased function of ATGL develop neutral lipid storage disease with myopathy (NLSDM), an autosomal recessive disorder. This evidence concerns the gene PNPLA2 and neutral lipid storage disease.